Effect of Minoxidil Solution Iontophoresis on Androgenic Alopecia
ConditionAlopecia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-65
SponsorCairo University
About this trial
The aim of the study is to evaluate the therapeutic efficiency of minoxidil solution iontophoresis on Androgenic Alopecia.
Eligibility criteria
Qualifiers
Twenty-five adult aged 18-65 with diagnosed androgenic alopecia.
They diagnosed as Androgenic alopeacia by their physicians and referred for physical therapy management.
Medically and psychologically stable patients.
Disqualifiers
History of hypersensitivity to minoxidil solution or Intophoresis.
Scalp infection
Concurrent hair loss treatments.
Patients who suffer from hypertrophic and/or keloidal scars and a skin condition in the area of Androgenic alopecia that would interfere with study procedures.
Trial design
Treatments tested in this trial
- Minoxidil solution iontophoresis
- saline solution iontophoresis
Treatment groups
25 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov